Records containing: Nonalcoholic Steatohepatitis (NASH)
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2021-07-27A Randomized Study to Compare the Efficacy of Vitamin E, Ursodeoxycholic Acid and Pentoxyfylline on Egyptian Patients With Non-alcoholic Fatty Liver Disease Using (IL6 and CCL2) as a Predictors of Non-alcoholic Steatohepatitis
-
CLINICAL_TRIALS study record update · 2021-06-04A Phase I Clinical Trial to Evaluate the Safety, Tolerability, Pharmacokinetics (PK) of XZP-5610 Tablets Following Single- and Multiple-ascending Doses (SAD/MAD) and Food Effects in Healthy Subjects.
-
CLINICAL_TRIALS study record update · 2021-05-07A Randomized, Double-Blind, Placebo-Controlled Study of Ascending Multiple Doses to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics，and Randomized, Open-label，Crossover, Food Effect Study of HEC96719 in Healthy Chinese Subjects
-
CLINICAL_TRIALS study record update · 2020-12-28A Phase I, Single Center, Randomized, Double-blind, Placebo-controlled, Single Ascending Dose Study to Access the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of HEC96719 Tablets in Chinese Healthy Volunteers
-
CLINICAL_TRIALS study record update · 2020-12-17A Phase 1 Open-Label, Parallel-Group, Single-Dose Study to Evaluate the Pharmacokinetics of GS-0976 or Fenofibrate in Subjects With Normal and Impaired Hepatic Function
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2020-10-12A Phase 1 Study in Healthy Volunteers to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of GS-9674, and the Effect of Food on GS-9674 Pharmacokinetics and Pharmacodynamics
-
CLINICAL_TRIALS study record update · 2020-09-30A Phase 1 Open-Label, Parallel-Group, Adaptive, Single-Dose Study to Evaluate the Pharmacokinetics and Pharmacodynamics of GS-9674 in Subjects With Normal and Impaired Hepatic Function
-
CLINICAL_TRIALS study record update · 2020-07-24A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Safety, Tolerability, and Efficacy of GS-0976 in Subjects With Nonalcoholic Steatohepatitis
-
CLINICAL_TRIALS study record update · 2020-01-13Tesamorelin Effects on Liver Fat and Histology in HIV: A Collaborative UO1 Grant
-
CLINICAL_TRIALS study record update · 2019-08-13A Phase 1 Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study to Evaluate the Safety, Tolerability and Pharmacokinetics of ZSP1601 and the Effect of Food on ZSP1601 Pharmacokinetics in Chinese Healthy Subjects.
-
CLINICAL_TRIALS study record update · 2019-03-04Feasibility of Vigorous-Intensity Interval Training in Adults With Nonalcoholic Steatohepatitis
-
CLINICAL_TRIALS study record update · 2019-01-29A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Safety, Tolerability, and Efficacy of GS-9674 in Subjects With Nonalcoholic Steatohepatitis (NASH)
-
CLINICAL_TRIALS study record update · 2018-09-20Comparison of Magnetic Resonance and Ultrasound Elastography With Liver Biopsy for Noninvasive Staging of Liver Fibrosis
-
CLINICAL_TRIALS study record update · 2015-08-21The Farnesoid X Receptor (FXR) Ligand Obeticholic Acid in Nonalcoholic Steatohepatitis (NASH) Treatment (FLINT) Trial
-
CLINICAL_TRIALS study record update · 2013-07-24Fish Oil and Diet for the Treatment of Non-Alcoholic Steatohepatitis (NASH)
-
CLINICAL_TRIALS study record update · 2012-07-12Association of Non-alcoholic Fatty Liver Disease and Coronary Artery Disease